Moeller Takes P&G Reins With 33-Year Grasp Of Products, Planning And Footprint
Executive Summary
Jon Moeller appointed to succeed David Taylor, at the helm for almost six years and remaining as executive chairman, a day before P&G releases FY21 full-year and Q4 results.
You may also be interested in...
US Q3 Consumer Health Earnings Preview: Coming Changes Overshadow Current Conditions?
Rather than reflecting what’s coming in the way of spinoffs, leadership, product approvals or deal closings, firms’ July-September results will reveal influences from inflation and supply chain problems. Like manufacturers across industries, US consumer health product firms are dealing with US currency strengthening and potentially driving down revenues through losses in foreign exchange.
Change At P&G Helm But Not In Course
Speaking at conferences or in P&G’s earnings briefings wasn’t part of previous CEO David Taylor’s strategy. But Jon Moeller has been a mainstay of P&G presentations for years and likely will continue the role.
Groomed For Sustainable Growth, P&G Positions Shaving Brands To Provide Marketplace Edge
In first presentation at P&G’s helm, Jon Moeller says firm was groomed under his predecessor to grow revenues and income by developing line extensions for daily-use products offered at premium prices and by simplifying its operations for efficiency from executive suites to local distribution channels.